These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 17170079

  • 1. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N, Hill AD, Young LS.
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [Abstract] [Full Text] [Related]

  • 2. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z, Ge L, Wang M, Carr BI.
    J Cell Physiol; 2006 Jul 01; 208(1):133-40. PubMed ID: 16596619
    [Abstract] [Full Text] [Related]

  • 4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 01; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 5. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 6. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME.
    Int J Oncol; 2007 Oct 01; 31(4):705-11. PubMed ID: 17786300
    [Abstract] [Full Text] [Related]

  • 7. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A, Buchholz M, Wagner M, Adler G, Gress T, Ellenrieder V.
    Mol Cancer Res; 2006 Nov 01; 4(11):861-72. PubMed ID: 17114344
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
    Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, Kawaguchi Y, Fujimoto K, Wada M, Miyatake S, Imamura M.
    Surgery; 2005 Aug 01; 138(2):299-305. PubMed ID: 16153440
    [Abstract] [Full Text] [Related]

  • 9. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R, Chen JM, Huard S, Wang E.
    J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342
    [Abstract] [Full Text] [Related]

  • 10. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z, Ontsouka EC, Jakob S, Torgler R, Falus A, Mueller C, Brunner T.
    Exp Cell Res; 2004 Sep 10; 299(1):227-35. PubMed ID: 15302589
    [Abstract] [Full Text] [Related]

  • 11. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ.
    Cancer Res; 2006 May 15; 66(10):5330-7. PubMed ID: 16707459
    [Abstract] [Full Text] [Related]

  • 12. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element.
    Manfroid I, Van de Weerdt C, Baudhuin A, Martial JA, Muller M.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):127-39. PubMed ID: 15607537
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
    Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA, Barker S, Yamaoto M, Li F, Alvarez RD, Curiel DT.
    Cancer Gene Ther; 2004 Apr 14; 11(4):256-62. PubMed ID: 15017380
    [Abstract] [Full Text] [Related]

  • 14. Krüppel-like factor 4 represses transcription of the survivin gene in esophageal cancer cell lines.
    Zhang G, Zhu H, Wang Y, Yang S, Liu M, Zhang W, Quan L, Bai J, Liu Z, Xu N.
    Biol Chem; 2009 Apr 14; 390(5-6):463-9. PubMed ID: 19361279
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
    Pawar SA, Szentirmay MN, Hermeking H, Sawadogo M.
    Oncogene; 2004 Aug 12; 23(36):6125-35. PubMed ID: 15208653
    [Abstract] [Full Text] [Related]

  • 16. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
    Yeh CW, Huang SS, Lee RP, Yung BY.
    Mol Pharmacol; 2006 Oct 12; 70(4):1443-53. PubMed ID: 16857742
    [Abstract] [Full Text] [Related]

  • 17. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Feb 12; 113(3):443-56. PubMed ID: 18327707
    [Abstract] [Full Text] [Related]

  • 18. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M, Seger D, Kreizman T, Badikhi D, Margalit R, Eilam R, Degani H.
    Endocr Relat Cancer; 2009 Sep 12; 16(3):819-34. PubMed ID: 19398483
    [Abstract] [Full Text] [Related]

  • 19. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ, Zhou Z, Huang J, Chaudhury L, Dong JT, Chen C.
    Oncogene; 2009 Oct 22; 28(42):3702-13. PubMed ID: 19668233
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.
    Clin Cancer Res; 2005 May 01; 11(9):3184-90. PubMed ID: 15867211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.